title: Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia.
authors.affiliation: Dept. of Internal Medicine, University of Ulm, FRG.
authors.forename: E
authors.initials: E
authors.lastname: Kurrle
authors.forename: G
authors.initials: G
authors.lastname: Ehninger
authors.forename: E
authors.initials: E
authors.lastname: Fackler-Schwalbe
authors.forename: M
authors.initials: M
authors.lastname: Freund
authors.forename: G
authors.initials: G
authors.lastname: Heil
authors.forename: D
authors.initials: D
authors.lastname: Hoelzer
authors.forename: H
authors.initials: H
authors.lastname: Link
authors.forename: B
authors.initials: B
authors.lastname: Löffler
authors.forename: A
authors.initials: A
authors.lastname: Lösch
authors.forename: P S
authors.initials: PS
authors.lastname: Mitrou
mesh_terms: D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003561:Cytarabine / Q000008:administration & dosage* / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D015479:Leukemia, Myelomonocytic, Acute / Q000188:drug therapy* / Q000401:mortality; D015993:Life Tables; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D011446:Prospective Studies; D015996:Survival Rate
chemical_list: D003561:Cytarabine; D005047:Etoposide; D003630:Daunorubicin